Skip to main content
. 2022 Jun 30;13:931531. doi: 10.3389/fphar.2022.931531

TABLE 1.

ADME core gene panel.

Gen Transcript (NCBI) Class
ABCB1 NM_001348946.2 Transporter
ABCC2 NM_000392.5 Transporter
ABCG2 NM_000392.5 Transporter
CYP1A1 NM_001319217.2 Phase I
CYP1A2 NM_000761.5 Phase I
CYP2A6 NM_000762.6 Phase I
CYP2B6 NM_000767.5 Phase I
CYP2C19 NM_000769.4 Phase I
CYP2C8 NM_000770.3 Phase I
CYP2C9 NM_000771.4 Phase I
CYP2D6 NM_000106.6 Phase I
CYP2E1 NM_000773.4 Phase I
CYP3A4 NM_017460.6 Phase I
CYP3A5 NM_000777.5 Phase I
DPYD NM_000110.4 Phase I
DRD2 NM_000795.4 Pharmacodynamic
GSTM1 NM_000561.4 Phase II
GSTP1 NM_000852.4 Phase II
GSTT1 NM_000853.3 Phase II
NAT1 NM_000662.8 Phase II
NAT2 NM_000015.3 Phase II
SLC15A2 NM_021082.4 Transporter
SLC22A1 NM_003057.3 Transporter
SLC22A2 NM_003058.4 Transporter
SLC22A6 NM_153276.3 Transporter
SLCO1B1 NM_006446.5 Transporter
SLCO1B3 NM_019844.4 Transporter
SULT1A1 NM_001055.3 Phase II
TPMT NM_000367.4 Phase II
UGT1A1 NM_000463.3 Phase II
UGT1A9 NM_019076.4 Phase II
UGT2B15 NM_001076.4 Phase II
UGT2B17 NM_001077.3 Phase II
UGT2B7 NM_001074.4 Phase II
VKORC1 NM_024006.6 Pharmacodynamic